In this week’s EuroBiotech Report, Shire impressed analysts with its bullish forecasts for sales growth between now and 2020, while also taking steps to ensure its pipeline is well stocked beyond that date by moving antibody candidates discovered in its 2012 alliance with arGEN-X into preclinical development. And more.

…read more

Source: Shire steps up arGEN-X alliance, Big Pharma gives MRC drugs, Woodford backs Midatech IPO


0 No comments